Brentuximab Vedotin and Nivolumab in Treating Patients With Early Stage Classic Hodgkin Lymphoma

Clinical trial NCT03712202 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03712202
Sponsor: City of Hope Medical Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Ann Arbor Stage I Hodgkin Lymphoma Ann Arbor Stage I Mixed Cellularity Classic Hodgkin Lymphoma Ann Arbor Stage I Nodular Sclerosis Classic Hodgkin Lymphoma Ann Arbor Stage IA Hodgkin Lymphoma Ann Arbor Stage IB Hodgkin Lymphoma Ann Arbor Stage II Hodgkin Lymphoma Ann Arbor Stage IIA Hodgkin Lymphoma Ann Arbor Stage IIB Hodgkin Lymphoma Classic Hodgkin Lymphoma Lymphocyte-Rich Classic Hodgkin Lymphoma Ann Arbor Stage I Lymphocyte-Depleted Classic HL Ann Arbor Stage II Lymphocyte-Depleted Classic HL

Start date: 2018-11-28
Primary completion: 2024-12-23
Enrollment: 155

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.